Benefits and Harm of Treatment with P2Y12 Inhibitors beyond 12 Months in Patients with Coronary Artery Disease
Mads Lamm Larsen(Aarhus University), Anne‐Mette Hvas(Aarhus University), Erik Lerkevang Grove(Aarhus University Hospital), Steen Dalby Kristensen(Aarhus University)
Cited by 1
Related Papers
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Platelet characteristics in patients with essential thrombocytosis
|Cytometry Part B Clinical Cytometry|2018|46
Prognostic Value of Coronary CT Angiography–derived Fractional Flow Reserve on 3-year Outcomes in Patients with Stable Angina
|Radiology|2023|42